SuspendedNot Applicable

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

Stopped: Because of COVID-19 Crisis

Egypt200 participantsStarted 2020-12-18

Plain-language summary

This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients with hypersensitivity to either Trospium chloride or Tamsulosin
✕. Patients with complications after DJ insertion (such as fever, hematuria, perforation, stent migration).
✕. Patients receiving alpha blockers or anticholinergic medications for any other reason.
✕. Patients with history of orthostatic hypotension.
✕. Pregnant or breastfeeding females.
✕. Patients with hepatic impairment (Child-Pugh score \>9).
✕. Patients with severe renal impairment with creatinine clearance of less than 15 mL/min.
✕. Patients with narrow-angle glaucoma.

What they're measuring

Ureteral Stent Symptoms Questionnaire (USSQ) score

Timeframe: 14 days

Trial details

NCT IDNCT03709992

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-01

View on ClinicalTrials.gov More Ureter Stone trials